From ZeroHedge: America’s obsessing with gun violence has pushed gunmakers like Smith & Wesson Holding Corp (NASDAQ:SWHC) to record sales and their stock to all-time highs.
Drug giant Pfizer Inc. (NYSE:PFE) on Tuesday posted estimate-beating earnings results and reaffirmed its full-year outlook, but the shares lost ground in early trading after a prolonged run-up heading into the report.
Michael Snyder: Oil briefly touched under $40 per barrel this morning, and with more losses in sight, it pays to take a look at how cheap oil will hurt the ongoing economic recovery.
From Chris Vermeulen: With half of Americans not invested at all in the stock market, it’s easy to see why consumer confidence is low, despite the S&P 500 hitting all-time highs.
From Chris Ciovacco: The recent price action in the Dow Jones Industrial Average and other key indexes simply isn’t confirming the consensus’ pessimistic view of the markets, which means there may be big opportunities to the upside.
The iPath S&P 500 VIX Short Term Futures ETN (NYSE:VXX) put up another losing day today, its 19th negative session out of the past 20.
ETF issuer Direxion Shares just released some interesting performance data for July, and if you were bullish gold miners, then you may have had a heck of a month.
Social media king Facebook Inc. (NASDAQ:FB) received some bullish commentary from analysts at MKM Partners today, adding further fuel to an already impressive 2016 for the stock.
Investors’ risk appetite continues to grow, and the search for both capital appreciation and yield is turning to our neighbors in emerging markets overseas.
In another sign that June’s Brexit scare was just a temporary blip on investors’ radars, just-released data shows that a combination of three popular S&P 500 ETFs saw enormous inflows in July.
Drugmaker Pfizer Inc. (NYSE:PFE) on Monday announced the acquisition of a gene therapy company Bamboo Therapeutics, which helped spike PFE to its highest levels since 2004.
The iShares NASDAQ Biotechnology Index ETF (NASDAQ:IBB) is breaking out to new six-month highs this morning, driven in no small part by a big drug development win by Biogen Inc (NASDAQ:BIIB).
From Ross Crooks III: Two weeks ago the European Central Bank further reassured the world that it is ready to save the day if and when the day needs saving. (That means more stimulus.) Then this past week, the Bank of Japan had the same opportunity but didn’t come off nearly as encouraging.
Retail megapower Amazon.com, Inc. (NASDAQ:AMZN) received bullish analyst commentary from two Wall Street firms Monday morning, the latest in a long string of positive notes.
In a recent interview, precious metals expert Eric Sprott detailed his thoughts on where silver could be headed for the next several weeks.